Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
VVT MedVVTMF 2 Equity-to-Asset is -2.76 as of Mar. 2026. GuruFocus rates VVTMF with a GF Score™ of 2/100. The stock has 5 warning signs investors should review. Among 851 Medical Devices & Instruments companies, VVT Med ranks worse than 97.3% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. VVT Med's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $-2.34 Mil. VVT Med's Total Assets for the quarter that ended in Mar. 2026 was $0.85 Mil.
Therefore, VVT Med's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was -2.76.
The historical rank and industry rank for VVT Med's Equity-to-Asset or its related term are showing as below:
VVTMF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -7.36 Med: -3.7 Max: -0.3
Current: -2.77
During the past 4 years, the highest Equity to Asset Ratio of VVT Med was -0.30. The lowest was -7.36. And the median was -3.70.
VVTMF's Equity-to-Asset is ranked worse than 97.3% of 851
companies
in the Medical Devices & Instruments industry
Industry Median: 0.64
vs VVTMF: -2.77
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
VVT Med Equity-to-Asset Related Terms
VVT Med Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for VVT Med's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVTMF vs ABT, SYK, MDT: Equity-to-Asset Comparison
For the Medical Devices subindustry, VVT Med's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
VVT Med Equity-to-Asset vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, VVT Med's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where VVT Med's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
VVT Med's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VVT Med (VVTMF) has a Equity-to-Asset of -2.76 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on VVT Med and its competitors. According to the industry distribution chart, VVT Med ranks #828 out of 851 companies in the Medical Devices & Instruments industry, placing it in the top 97.3%.
Is VVT Med's Equity-to-Asset too high?
VVT Med's current Equity-to-Asset is -2.76. Based on the distribution chart, VVT Med ranks #828 out of 851 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, VVT Med has a GF Score™ of 2/100, reflecting its overall financial health beyond just this single metric.
How does VVT Med's Equity-to-Asset compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, VVT Med ranks #828 out of 851 companies for Equity-to-Asset. This places VVT Med in the lower half of its industry. The industry median Equity-to-Asset is 0.64. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Medical Devices & Instruments company?
The median Equity-to-Asset among Medical Devices & Instruments companies is 0.64, based on 851 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on VVT Med and its competitors. For the Medical Devices & Instruments industry, the median Equity-to-Asset is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. VVT Med's current Equity-to-Asset is -2.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is VVT Med stock overvalued right now?
VVT Med (VVTMF) has a current Equity-to-Asset of -2.76. The current Equity-to-Asset is -2.76. VVT Med's overall GF Score™ is 2/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For VVT Med (VVTMF), the current Equity-to-Asset is -2.76 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
VVT Med Inc is a medical device company, focused on developing and commercializing a range of minimally invasive technologies for treating varicose veins. VVT's research and development activities are based in Israel. The company proudly boasts three products within its portfolio that have achieved commercial production status and are currently available in the market. These products have undergone meticulous design processes, obtaining regulatory approvals across multiple countries.
2GF Score
Get the complete analysis for VVTMF
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VVTMF has been successfully added to your 
